New ultrasound trick could replace costly scans for common liver tumors

NCT ID NCT07418294

Recruiting now Diagnosis Sponsor: Yonsei University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new computer-based ultrasound technique called Fluctuational Imaging (FLI) to diagnose hepatic hemangiomas, the most common benign liver tumors. Researchers will enroll 400 adults with liver lesions to see if FLI can reliably tell hemangiomas apart from other growths. If it works, FLI could reduce the need for contrast-enhanced CT or MRI scans, lowering healthcare costs and avoiding radiation or contrast risks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Fluctuational Imaging (FLI) software algorithm
What this could lead to: If successful, FLI could allow doctors to diagnose liver hemangiomas using only ultrasound, avoiding the need for contrast CT or MRI scans.
What could go wrong: This is an early-stage study with 400 participants, and FLI's accuracy may vary depending on the operator or lesion type. It may not work for all liver lesions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMANGIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hemangioma liver hemangioma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMANGIOMA

Contacts and locations

Locations

Severance hospital, Yonsei university college of medicine
RECRUITING

Seoul, Seodaemun-gu, 03722, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.